In glioblastoma, RCC2 is implicated in tumor proliferation, tumorigenicity, and promoting radio-resistance by activating DNA methyltransferase 1 (DNMT1) transcription in a p-STAT3 dependent manner (Yu et al., 2019). Here, RCC2 is linked to neoplasm.